AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 25891453
Drug: Traditional Chinese
RxNorm normalized name: BORNEOL 1 g in 6.5 g / MINT 1 g in 6.5 g / ANGELICA DAHURICA ROOT 0.5 g in 6.5 g TOPICAL POWDER [Traditional Chinese Medicine Health Card and TCM Epidemic Prevention Card]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional Chinese medicine (TCM) combination group
Trial: 25891453
Drug: Western medicine
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Western medicine control group
Trial: 19335912
Drug: Cardiac index
RxNorm normalized name: Leonurus cardiaca extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cardiac index (CI) >or= 3.0 L/min/m2
Trial: 20938444
Drug: Erythromycin (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythromycin (3 mg Kg(‐1) infusion for 1 hour)
Trial: 18708300
Drug: Oxycodone PR/naloxone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxycodone PR/naloxone PR
Trial: 25198235
Drug: Deadlift training
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deadlift training (twice per week)
Trial: 22267245
Drug: sodium bicarbonate
RxNorm normalized name: Sodium Bicarbonate
DrugBank: Sodium bicarbonate (DB01390)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: sodium bicarbonate (166 mEq/L) 3 mL/kg for 1 h before and 1 mL/kg/h for 6 h after the procedure (Group B)
Trial: 22267245
Drug: sodium chloride
RxNorm normalized name: Sodium Chloride
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: sodium chloride 0.9% 1 mL/kg/h for at least 12h prior and after the procedure (Group A)
Trial: 22267245
Drug: sodium bicarbonate
RxNorm normalized name: Sodium Bicarbonate
DrugBank: Sodium bicarbonate (DB01390)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: sodium bicarbonate (166 mEq/L) 3 mL/kg over 20 min before the procedure plus sodium bicarbonate orally (500 mg per 10 kg) (Group C)
Trial: 17192294
Drug: rhIGF‐I administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rhIGF‐I administered sc in doses between 60 and 120 microg/kg twice daily
Trial: 14712431
Drug: 4 hours
RxNorm normalized name: PATCH, TRANSDERMAL 24 HOURS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 hours dialysis 3 times weekly
Trial: 14712431
Drug: 5 hours
RxNorm normalized name: buprenorphine
DrugBank: Buprenorphine (DB00921)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: 5 hours dialysis 3 times weekly
Trial: 9887898
Drug: Antibiotics (Western
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotics (Western medicine)
Trial: 7986302
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg of fluvastatin once daily for 6 weeks
Trial: 7986302
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg of fluvastatin twice daily for 6 weeks
Trial: 7986302
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg of fluvastatin (both dosages)
Trial: 2554766
Drug: LY171883 (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LY171883 (600 mg) twice daily for 6 weeks
Trial: 23635604
Drug: Spironolactone (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spironolactone (25 mg) administered 1 day before and 3 days posttransplantation
Trial: 16393591
Drug: L.M.X.4 cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L.M.X.4 cream (4% liposomal lidocaine)
Trial: 16393591
Drug: EMLA cream
RxNorm normalized name: LIDOCAINE 25 mg in 1 g / PRILOCAINE 25 mg in 1 g TOPICAL CREAM [Emla Cream]
DrugBank: Prilocaine (DB00750)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: EMLA cream (2.5% lidocaine and 2.5% prilocaine)
Trial: 10768435
Drug: 1200 mg
RxNorm normalized name: aspirin 1200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1200 mg of anti-digoxin Fab
Trial: 8829177
Drug: Ethanol (0.07
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ethanol (0.07 +/- 0.003 g/dl)
Trial: 1425887
Drug: Mianserin (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mianserin (60 mg per day)
Trial: 1425887
Drug: Imipramine (dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imipramine (dose adjusted for optimal plasma concentration of 400-600 nmol.l-1)
Trial: 2865152
Drug: Propranolol, Metoprolol,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol, Metoprolol, Pindolol (lipophilic beta-blockers)
Trial: 2865152
Drug: Atenolol (hydrophilic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol (hydrophilic beta-blocker)
Trial: 21935377
Drug: 3% SPL7013
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3% SPL7013 Gel (VivaGel)
Trial: 19752076
Drug: Rectal dimenhydrinate
RxNorm normalized name: Dimenhydrinate
DrugBank: Dimenhydrinate (DB00985)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Rectal dimenhydrinate
Trial: 17179265
Drug: Lidocaine (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine (2 mg/kg IV for 5 min, followed by 3 mg x kg(‐1) x h(‐1) for 10 min)
Trial: 11548874
Drug: Losartan (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan (50 mg/day for 4 weeks)
Trial: 11548874
Drug: Bisoprolol (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bisoprolol (5 mg/day for 4 weeks)
Trial: 9718471
Drug: Fluconazole 150
RxNorm normalized name: fluconazole 150 MG
DrugBank: Fluconazole (DB00196)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fluconazole 150 mg single dose
Trial: 9718471
Drug: Itraconazole 100
RxNorm normalized name: itraconazole 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Itraconazole 100 mg for 7 days
Trial: 30457018
Drug: Itopride HCl
RxNorm normalized name: itopride HCl
DrugBank: Itopride (DB04924)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Itopride HCl 150 mg ER pellets
Trial: 30457018
Drug: Ganaton ER
RxNorm normalized name: Genaton
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ganaton ER 150 mg OD tablets
Trial: 11523071
Drug: Test treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test treatment (three doses)
Trial: 28721837
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (CRT) - ≥1 serving/d (25-30 g) carbohydrates
Trial: 25084499
Drug: Stigma reduction
RxNorm normalized name: reductic acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stigma reduction intervention (video watched weekly for 4 weeks)
Trial: 22562296
Drug: Topical ketorolac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical ketorolac tromethamine 0.4% eyedrops
Trial: 16986068
Drug: Standard dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard dose of proton pump inhibitor (PPI) until symptoms resolve for NERD or until complete remission for erosive disease.
Trial: 16986068
Drug: Half-dose PPI
RxNorm normalized name: propranolol hydrochloride Extended Release Oral Capsule [Half-Betadur CR]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Half-dose PPI for maintenance treatment.
Trial: 16986068
Drug: On-demand therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: On-demand therapy with half-dose PPI for NERD patients in remission.
Trial: 16986068
Drug: Return to
RxNorm normalized name: Wong To Yick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Return to full-dose PPI for relapse of symptoms.
Trial: 16986068
Drug: Long-term treatment
RxNorm normalized name: benzethonium
DrugBank: Benzethonium (DB11125)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Long-term treatment with PPIs.
Trial: 8735555
Drug: HDCV (standard
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HDCV (standard human diploid cell rabies vaccine)
Trial: 8735555
Drug: ALVAC-RG (lowest
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ALVAC-RG (lowest dose 10^3.5 TCID50)
Trial: 8735555
Drug: ALVAC-RG (booster
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ALVAC-RG (booster dose at day 180)
Trial: 31233507
Drug: IDA (ivermectin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IDA (ivermectin 200 μg/kg, diethylcarbamazine 6 mg/kg, albendazole 400 mg)
Trial: 28128223
Drug: Intravenous saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous saline post procedure (Group A)
Trial: 28128223
Drug: No intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No intravenous fluids post-procedure (Group B)
Trial: 17173514
Drug: Acetazolamide (750
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetazolamide (750 mg PO daily)
Trial: 14505753
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg of mifepristone administered on day LH+2
Trial: 2908814
Drug: Fenoldopam 50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenoldopam 50 mg
Trial: 2908814
Drug: Fenoldopam 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenoldopam 100 mg
Trial: 2908814
Drug: Fenoldopam 150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenoldopam 150 mg
Trial: 2908814
Drug: Metoclopramide 20
RxNorm normalized name: metoclopramide 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoclopramide 20 mg + Fenoldopam 100 mg
Trial: 2908814
Drug: Metoclopramide 20
RxNorm normalized name: metoclopramide 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoclopramide 20 mg + Placebo
Trial: 20019137
Drug: Total Body
RxNorm normalized name: Total Body Massager Item
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total Body Weight (TBW) group (0.6 g of iodine per kilogram of TBW)
Trial: 20019137
Drug: Lean Body
RxNorm normalized name: Cleanser Topical application Soap [NIVEA MEN ACTIVE CLEAN BODY WASH]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lean Body Weight (LBW) group (0.821 g of iodine per kilogram of LBW)
Trial: 20019137
Drug: Blood Volume
RxNorm normalized name: dragon's blood extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Blood Volume (BV) group (men, 8.6 g of iodine per liter of BV; women, 9.9 g of iodine per liter of BV)
Trial: 18024370
Drug: Induction therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Induction therapy with idarubicin and cytarabine plus lomustine (ICL)
Trial: 18024370
Drug: Induction therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Induction therapy with idarubicin and cytarabine (IC)
Trial: 16118354
Drug: Preoperative morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preoperative morphine (10 mg IV) and postoperative OMT
Trial: 16118354
Drug: Preoperative saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preoperative saline (control) and postoperative sham manipulative treatment
Trial: 16118354
Drug: Preoperative morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preoperative morphine (10 mg IV) and postoperative sham manipulative treatment
Trial: 11383326
Drug: 10 mg/d
RxNorm normalized name: Arixtra 10 mg/dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg/d atorvastatin for 10 or more weeks
Trial: 11383326
Drug: 1.68 g/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.68 g/d omega-3 FA (ethylesters of eicosapentaenoic and docosahexaenoic acids)
Trial: 9734349
Drug: Steroid nonusers
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Steroid nonusers
Trial: 3057655
Drug: Warfarin (Petersen)
DrugBank: Warfarin (DB00682)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Warfarin (Petersen)
Trial: 3057655
Drug: Warfarin (Lennon)
DrugBank: Warfarin (DB00682)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Warfarin (Lennon)
Trial: 25365753
Drug: Recombinant, live,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Recombinant, live, attenuated, tetravalent dengue vaccine (CYD-TDV)
Trial: 21842613
Drug: Active drug
RxNorm normalized name: Capillary active drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active drug (specific drug not mentioned)
Trial: 21842613
Drug: Higher dose
RxNorm normalized name: BENZOCAINE 50 mg in 1 mL TOPICAL GEL [HIGHER CONTROL Male Climax Control Lubricating]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher dose or augmentation agent
Trial: 16467768
Drug: 200mg itraconazole
RxNorm normalized name: itraconazole 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200mg itraconazole twice daily during the first week of a 4 weeks cycle for 16 weeks
Trial: 16467768
Drug: 250mg terbinafine
RxNorm normalized name: terbinafine 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250mg terbinafine twice daily during the first week of a 4 weeks cycle for 16 weeks
Trial: 6687578
Drug: Agiolax (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Agiolax (15 mg senna glucosides)
Trial: 6687578
Drug: Lunelax comp.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lunelax comp. (25 mg senna glucoside A + B)
Trial: 25961147
Drug: Social Behavior
RxNorm normalized name: Safety 1st Social Safety Pack KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Social Behavior and Network Therapy (SBNT)
Trial: 27780504
Drug: PFNA combined
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PFNA combined with zoledronic acid injection (5 mg/100 ml via intravenous drip)
Trial: 27780504
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (PFNA with 600 mg of Caltrate D and 0.25 mg of alpha ossification alcohol)
Trial: 18853704
Drug: Ramelteon 1
RxNorm normalized name: Ramelteon
DrugBank: Ramelteon (DB00980)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ramelteon 1 mg once daily for 4 days
Trial: 18853704
Drug: Ramelteon 2
RxNorm normalized name: Ramelteon
DrugBank: Ramelteon (DB00980)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ramelteon 2 mg once daily for 4 days
Trial: 18853704
Drug: Ramelteon 4
RxNorm normalized name: Ramelteon
DrugBank: Ramelteon (DB00980)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ramelteon 4 mg once daily for 4 days
Trial: 18853704
Drug: Ramelteon 8
RxNorm normalized name: ramelteon 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ramelteon 8 mg once daily for 4 days
Trial: 14619332
Drug: Omalizumab, 300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omalizumab, 300 mg, administered subcutaneously every 4 weeks (three injections) for IgE levels < or = 150 IU/mL and every 3 weeks (four injections) for IgE levels > 150 IU/mL.
Trial: 1747004
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg of fluconazole daily for 12 weeks
Trial: 1747004
Drug: No fluconazole
RxNorm normalized name: Fluconazole
DrugBank: Fluconazole (DB00196)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: No fluconazole treatment
Trial: 6341070
Drug: Diphenylhydantoin (PHT,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diphenylhydantoin (PHT, 200 mg/day)
Trial: 6341070
Drug: Diphenylhydantoin (PHT,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diphenylhydantoin (PHT, 300 mg/day)
Trial: 6341070
Drug: Carbamazepine (CBZ,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbamazepine (CBZ, 600 mg/day)
Trial: 6341070
Drug: Carbamazepine (CBZ,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbamazepine (CBZ, 800 mg/day)
Trial: 6608483
Drug: Vitamin D2
RxNorm normalized name: vitamin D2
DrugBank: Ergocalciferol (DB00153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin D2 (50,000 IU p.o. two to three times weekly)
Trial: 6608483
Drug: 25-OH-D (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25-OH-D (20 to 50 mg p.o. daily as required)
Trial: 6608483
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no supplemental vitamin D treatment)
Trial: 28139626
Drug: Cerebrolysin 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cerebrolysin 20 ml per 200 ml of 0.9% NaCl solution, 1 time per day for 10 days (G1)
Trial: 28139626
Drug: 200 ml
RxNorm normalized name: Bag Top-Fill, 1200 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 ml 0.9% NaCl solution (G2)
Trial: 24925592
Drug: Insulin-requiring gestational
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin-requiring gestational diabetes
Trial: 21084077
Drug: HPV vaccine
RxNorm normalized name: HPV vaccine 9-valent/PF 0.5 mL INTRAMUSC VIAL (ML)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HPV vaccine awareness and intention to become vaccinated
Trial: 21084077
Drug: Awareness of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Awareness of HPV vaccine by ethnicity
Trial: 18689368
Drug: Dextrose plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dextrose plus 2.4 g amino acids . kg(‐1) . d(‐1)
Trial: 15714185
Drug: 0.2% ropivacaine/0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2% ropivacaine/0.5 mg mL(‐1) sufentanil
Trial: 10226122
Drug: Immediate treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate treatment with thermal balloon ablation (single intramuscular administration of GnRH analog)
Trial: 10226122
Drug: Delayed treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delayed treatment with thermal balloon ablation (without uterine preparation)
Trial: 1881743
Drug: Subcutaneous varicella
RxNorm normalized name: VARICELLA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous varicella vaccine
Trial: 1881743
Drug: Intramuscular varicella
RxNorm normalized name: VARICELLA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular varicella vaccine
Trial: 1881743
Drug: Both routes
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both routes (subcutaneous and intramuscular)
Trial: 26037514
Drug: Premeal insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Premeal insulin injection before a high-carbohydrate meal
Trial: 26037514
Drug: Control meal
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control meal with premeal saline injection
Trial: 24432671
Drug: Xiaoyan Zhitong
RxNorm normalized name: METHYL SALICYLATE 13 g / MENTHOL 9 g / CAMPHOR (SYNTHETIC) 11 g TOPICAL PATCH [KGS Zhitong Gao Medicated Plaster Extra Strength]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Xiaoyan Zhitong Paste (XZP), applied externally, one to two pastes each time, exchanged once per 24 hours, for a total of two 7-day treatment courses.
Trial: 19922896
Drug: Combined fixed-dose
RxNorm normalized name: Humalog Mix
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined fixed-dose formulation of ticlopidine 250 mg/ginkgo extract 80 mg
Trial: 19922896
Drug: Concomitant administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Concomitant administration of ticlopidine 250 mg and ginkgo extract 80 mg
Trial: 11600101
Drug: Subgroup of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subgroup of patients hospitalized for less than 2 months after antipsychotic medications were restored
Trial: 10423601
Drug: Moexipril 15
RxNorm normalized name: moexipril 15 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moexipril 15 mg once daily
Trial: 10423601
Drug: Moexipril 30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moexipril 30 mg once daily
Trial: 10423601
Drug: Moexipril 15
RxNorm normalized name: moexipril 15 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moexipril 15 mg + Hydrochlorothiazide 25 mg
Trial: 10423601
Drug: Moexipril 30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moexipril 30 mg + Hydrochlorothiazide 50 mg
Trial: 7884791
Drug: Moexipril monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moexipril monotherapy
Trial: 10423601
Drug: Diuretic or
RxNorm normalized name: Medicated Pad or Tape
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diuretic or combination treatment
Trial: 3359909
Drug: Intravenous fat
RxNorm normalized name: Hard fat
DrugBank: Hard fat (DB11578)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous fat (Intralipid 10%)
Trial: 3359909
Drug: Intraduodenal fat
RxNorm normalized name: Hard fat
DrugBank: Hard fat (DB11578)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraduodenal fat plus cholestyramine (20 g)
Trial: 3359909
Drug: All fat
RxNorm normalized name: Hard fat
DrugBank: Hard fat (DB11578)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: All fat infusion groups (Intravenous and Intraduodenal)
Trial: 3359909
Drug: Intravenous fat
RxNorm normalized name: Hard fat
DrugBank: Hard fat (DB11578)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous fat (group IV)
Trial: 28215316
Drug: Aronia extract
RxNorm normalized name: Aronia melanocarpa fruit extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aronia extract (500 mg daily)
Trial: 12899109
Drug: Indinavir with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indinavir with nucleoside-analogue reverse-transcriptase inhibitors (NRTI)
Trial: 12899109
Drug: NRTI monotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NRTI monotherapy
Trial: 29939894
Drug: Periarticular analgesic
RxNorm normalized name: Analgesic Balm GRX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Periarticular analgesic injection (PAI)
Trial: 26932345
Drug: Golimumab (GOL),
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Golimumab (GOL), administered subcutaneously, following a placebo control through weeks 16 and 24.
Trial: 22691654
Drug: Oral nonsteroidal
RxNorm normalized name: isopropyl alcohol
DrugBank: Isopropyl alcohol (DB02325)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral nonsteroidal anti‐inflammatory drug (NSAID)
Trial: 22691654
Drug: Intravenous (IV)
RxNorm normalized name: intravenous (IV) infusion pump
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous (IV) 10% mannitol and steroid
Trial: 22691654
Drug: IV 20%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV 20% mannitol and steroid with oral gabapentin